X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (664) 664
Conference Proceeding (257) 257
Book Review (63) 63
Publication (28) 28
Book Chapter (8) 8
Patent (4) 4
Dissertation (2) 2
Magazine Article (1) 1
Newspaper Article (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
index medicus (275) 275
humans (252) 252
cardiac & cardiovascular systems (228) 228
respiratory system (189) 189
female (155) 155
male (146) 146
pulmonary hypertension (142) 142
middle aged (118) 118
adult (102) 102
critical care medicine (92) 92
hypertension, pulmonary - drug therapy (87) 87
treatment outcome (78) 78
aged (76) 76
hypertension (69) 69
abridged index medicus (65) 65
therapy (58) 58
hypertension, pulmonary - physiopathology (56) 56
pulmonary arterial hypertension (56) 56
survival (50) 50
diagnosis (45) 45
drug therapy (45) 45
surgery (43) 43
double-blind method (42) 42
hypertension, pulmonary - diagnosis (42) 42
antihypertensive agents - therapeutic use (37) 37
care and treatment (37) 37
animals (36) 36
analysis (35) 35
double-blind (35) 35
bosentan (34) 34
continuous intravenous epoprostenol (32) 32
prognosis (32) 32
medicine, general & internal (31) 31
mortality (30) 30
adolescent (29) 29
hypertension, pulmonary - therapy (29) 29
hypertension, pulmonary - etiology (28) 28
pulmonary arteries (28) 28
research (28) 28
risk factors (28) 28
cardiovascular (27) 27
patients (27) 27
follow-up studies (26) 26
guidelines (24) 24
medicine & public health (24) 24
sulfonamides - therapeutic use (24) 24
disease (23) 23
dose-response relationship, drug (22) 22
inhaled iloprost (22) 22
registry (22) 22
sildenafil (22) 22
brain natriuretic peptide (21) 21
exercise (21) 21
internal medicine (21) 21
aged, 80 and over (20) 20
clinical trials (20) 20
endothelin (20) 20
hypertension, pulmonary - mortality (20) 20
management (20) 20
prostacyclin (20) 20
time factors (20) 20
cancer (19) 19
drug therapy, combination (19) 19
endothelin receptor antagonists (19) 19
familial primary pulmonary hypertension (19) 19
cardiology and cardiovascular medicine (18) 18
heart failure (18) 18
placebo-controlled trial (18) 18
prospective studies (18) 18
quality of life (18) 18
vasodilator agents - therapeutic use (18) 18
child (17) 17
hemodynamics (17) 17
hemodynamics - drug effects (17) 17
transplantation (17) 17
antihypertensive agents - administration & dosage (16) 16
calcium-channel blockers (16) 16
cardiology (16) 16
epoprostenol (16) 16
exercise test (16) 16
hypertension, pulmonary - complications (16) 16
life sciences (16) 16
pulmonary embolism (16) 16
rats (16) 16
severity of illness index (16) 16
treatments (16) 16
disease progression (15) 15
efficacy (15) 15
endothelin-receptor antagonist (15) 15
heart (15) 15
hypertension, pulmonary - epidemiology (15) 15
peripheral vascular disease (15) 15
pharmacology & pharmacy (15) 15
pulmonary (15) 15
pulmonary/respiratory (15) 15
young adult (15) 15
algorithms (14) 14
drug administration schedule (14) 14
echocardiography (14) 14
health aspects (14) 14
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (781) 781
Italian (28) 28
Romanian (27) 27
Spanish (19) 19
French (12) 12
German (8) 8
Polish (3) 3
Portuguese (3) 3
Turkish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Circulation, 05/2019, Volume 139, Issue 21, pp. 2440 - 2450
NT-proBNP (N-terminal pro brain natriuretic peptide) levels are included in the multiparametric risk assessment approach for pulmonary arterial hypertension... 
brain natriuretic peptide | hypertension, pulmonary | risk assessment | prostacyclin receptor
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2013, Volume 369, Issue 9, pp. 809 - 818
Journal Article
Chirurgia (Romania), ISSN 1221-9118, 2012, Volume 109, Issue 3, pp. 408 - 411
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2015, Volume 373, Issue 9, pp. 834 - 844
Journal Article
by Mendes-Ferreira, P and Maia-Rocha, C and Adao, R and Lourenco, A. P and Moura, C and Pinho, S and Areias, J. C and De Keulenaer, G. W and Leite-Moreira, A. F and Bras-Silva, C and Holzhauser, L and Lindner, D and Jenke, A and Schultheiss, H.- P and Westermann, D and Skurk, C and Misaka, T and Suzuki, S and Miyata, M and Kobayashi, A and Saitoh, S and Takeishi, Y and Czolbe, M and Pekarek, V and Williams, T and Panther, F and Strassen, J and Ritter, O and Voss, S and Nef, H. M and Szardien, S and Troidl, C and Kojonazarov, B and Visser, D and Hoffmann, J and Willmer, M and Hamm, C. W and Moellmann, H and Ljubojevic, S and Sedej, S and Sacherer, M and Leitinger, G and Kockskaemper, J and Pieske, B and Vorobyeva, N. M and Dobrovolsky, A. B and Titaeva, E. V and Kirienko, A. I and Panchenko, E. P and Nakamura, R and Matsue, Y and Mizukami, A and Ohno, M and Suzuki, M and Matsumura, A and Hashimoto, Y and Rosiak, M and Postula, M and Kaplon-Cieslicka, A and Trzepla, E and Czlonkowski, A and Filipiak, K. J and Opolski, G and Kosior, D. A and Andersson, T and Nagy, P and Niazi, M and Nylander, S and Wallentin, L and Mendell, J and Johnson, L and Ridout, G and He, L and Chen, S and Petrkova, M and Schneiderova, P and Kriegova, E and Kolar, Z and Taborsky, M and Petrek, M and Khuseyinova, N and Schnabel, R and Zeller, T and Gori, T and Schulz, A and Espinola-Klein, C and Lackner, K. J and Blankenberg, S and Muenzel, T. F and Wild, P. S and Amabile, N and Cheng, S and Larson, M. G and Ghorbani, A and Mc Cabe, E and Griffin, G and Cohen, K. S and Tedgui, A and Boulanger, C. M and Wang, T. J and ... and on behalf of BBC ONE investigators and on behalf of WHICH? Trial Investigators and on behalf of EPES Acute Cardiac Care group and on behalf of Interventional Genetic Study Group in Cardiovascular Disease's and on behalf of HPS2-THRIVE Collaborative Group and on behalf of Advantageous Predictors of Acute Coronary Syndrome Evaluation (APACE) and on behalf of The Milan and New-Tokyo Registry and on behalf of SAFETY Investigators and on behalf of Advance CRT Investigators and on behalf of the ARVA Investigators and on behalf of TIMI Study Group and on behalf of REFINE ICD Investigators and on behalf of RO-AHFS Study Investigators and on behalf of The PASCAL Investigators and on behalf of the KorHF investigators and on behalf of TECAM and on behalf of The INSIGHT (R)XT investigators and on behalf of ATA-AF investigators and on behalf of The ODIN Participants and on behalf of CREDO-Kyoto Registry Cohort-2 Investigators and on behalf of AHEAD investigators and on behalf of the RESET investigators and on behalf of ABSORB Cohort B and on behalf of RE-LY Trial Investigators and on behalf of the CORONA Study Group and on behalf of PROTECTOME and on behalf of CoLaus Study and on behalf of OFRECE Study and on behalf of BBK Registry and on behalf of FAST-MI 2010 and on behalf of ATOLL investigators and on behalf of HARVEST study group and on behalf of Royal Brompton Hospital NIHR Cardiovascular Biomedical Research Unit and on behalf of the PROSPER study group and on behalf of MAGGIC study group and on behalf of the DANPACE Investigators and on behalf of German Conn's Registry and on behalf of NANOPLASTY group and on behalf of j-Cypher Registry and on behalf of NIL-CHF Study Investigators and on behalf of the FAST-MI 2010 investigators and on behalf of Competence Network Heart Failure and on behalf of Gothia Cardiovascular and on behalf of OPTIMISE CRT Investigators and on behalf of EVEREST trial investigators and on behalf of The Tohoku Acute Heart Failure Registry and on behalf of investigators of the national registry of ACS, Portuguese Society of Cardiology and on behalf of BIOSOLVE-I Investigators and on behalf of Department of Cardiology, Second Hospital of Tianjin Medical University and on behalf of THALES Registry Investigators and on behalf of STICH Investigators and on behalf of Young @ Heart Investigators and on behalf of PROCARDIS Consortium and on behalf of PEGASO and on behalf of The SWEDEHEART group and on behalf of BWGIC (Belgian Working Group of Invasive Cardiology and on behalf of Med in NRW and For The Topp Registry Investigators and on behalf of PRISON and on behalf of ARISTOTLE investigators and on behalf of the RACE II investigators and on behalf of Euro Heart Survey PCI registry investigators and on behalf of the SPICE investigators and on behalf of The ISAR REACT 4 Investigators and on behalf of Yokohama Medical Center Clinical Research group and on behalf of DiaRegis-Study-Group and on behalf of The RHYTHM-AF Study Scientific Committee and on behalf of the Korea Acute Myocardial Infarction Registry and on behalf of AMIS Plus Investigators and on behalf of SYNTAX Investigators and on behalf of Advantage Predictors of Acute Coronary Syndrome Evaluation and on behalf of CREATE investigator group and on behalf of Follow Your Heart Project and on behalf of SYNTAX Trial Investigators and on behalf of WELCOME Study Investigators and on behalf of Arbeitsgemeinschaft Leitende Kardiologische Krankenhausarzte (ALKK) investigators and on behalf of investigators of the national registry of ACS, Portugese Society of Cardiology and on behalf of EVITA-HF (Evidence Based Treatment - Heart Failure) and on behalf of ESTROFA and on behalf of Second Department of Internal Medicine and on behalf of Korea Acute Myocardial Infarction Registry and on behalf of PRAGUE-2 and on behalf of German Diabetes and Dialysis Study Investigators and on behalf of Hull LifeLab and on behalf of on behalf of the DYDA Investigators and on behalf of OFICA study group and on behalf of BASKET-PROVE and on behalf of the Triple-Site versus Standard Resynchronization Therapy Study (TRUST CRT) Investigators and on behalf of Scripps Translational Science Institute and on behalf of OMEGA study group and on behalf of PL-ACS Invastigators and on behalf of German Aortic Valve Therapy Registry and on behalf of TO BELIEVERS and on behalf of PREDICTION Study Group and on behalf of The REACH registry investigators and on behalf of PL-ACS Investigators and on behalf of KNHI and on behalf of Emerging Concepts in Cardiovascular Medicine and on behalf of CHART-2 Investigators and on behalf of the Fushimi AF Registry investigators and on behalf of Brasilian Heart Study Group and on behalf of Taiwan acute coronary syndrome full spetrum registry study group
European Heart Journal, ISSN 0195-668X, 08/2012, Volume 33, Issue suppl 1, pp. 339 - 653
Journal Article
PLoS ONE, ISSN 1932-6203, 04/2019, Volume 14, Issue 4, pp. e0215464 - e0215464
Journal Article
Journal Article
The New England Journal of Medicine, ISSN 0028-4793, 08/2001, Volume 345, Issue 5, pp. 325 - 334
Journal Article